Mohammed Qatanani
Direttore Tecnico/Scientifico/R&S presso SCHOLAR ROCK HOLDING CORPORATION
Patrimonio netto: 1 M $ in data 31/05/2024
Posizioni attive di Mohammed Qatanani
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Direttore Tecnico/Scientifico/R&S | 01/09/2022 | - |
Storia della carriera di Mohammed Qatanani
Precedenti posizioni note di Mohammed Qatanani
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| DYNE THERAPEUTICS, INC. | Corporate Officer/Principal | 01/02/2018 | 01/09/2021 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/07/2015 | 01/01/2018 |
Formazione di Mohammed Qatanani
| American University of Beirut | Graduate Degree |
| Baylor College of Medicine | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
| Libano | 2 |
Posizioni
| Corporate Officer/Principal | 2 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| DYNE THERAPEUTICS, INC. | Health Technology |
| SCHOLAR ROCK HOLDING CORPORATION | Health Technology |
| Aziende private | 1 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- Mohammed Qatanani
- Esperienza
